Results 231 to 240 of about 10,829,007 (362)

Harnessing Natural Compounds in Psoriasis: Targeting Cellular Pathways for Effective Therapy

open access: yesPhytotherapy Research, EarlyView.
Natural compounds act on key cellular pathways in psoriasis by suppressing keratinocyte hyperproliferation, modulating Th17/IL‐17‐mediated immune responses, and reducing oxidative stress. These multi‐target effects highlight their potential as safer adjunctive therapies alongside conventional treatments.
Hye Jin Lee   +9 more
wiley   +1 more source

Characteristics related to biomarkers of neutrophil, eosinophil, and mast cell activation. [PDF]

open access: yesSci Rep
Sivander A   +6 more
europepmc   +1 more source

Diagnostic Criteria Of Mast Cell Sarcoma

open access: green, 2016
A. Efimov, M. Roytman, E. Rystsova
openalex   +1 more source

Nanoemulsions for Skin Delivery of Essential Oils: A Systematic Review

open access: yesPhytotherapy Research, EarlyView.
ABSTRACT Essential oils (EOs) are recognized for their multiple health benefits. However, their high volatility, low stability, and limited water solubility limit their effective application. This systematic review aims to assess the use of nanoemulsions as delivery systems for the topical administration of EOs, highlighting their efficacy, safety, and
Thais Leticia Moreira da Silva   +3 more
wiley   +1 more source

TIM-4 Regulates Allergic Airway Inflammation and Mast Cell Activation by Binding to CD300b. [PDF]

open access: yesJ Asthma Allergy
Tanabe Y   +15 more
europepmc   +1 more source

Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2–DP1 receptor paracrine axis

open access: yesNature Immunology, 2013
Y. Taketomi   +32 more
semanticscholar   +1 more source

Association of autoimmune diseases with biologic agents targeting type 2 immunity: An observational study using a claims database

open access: yesRheumatology &Autoimmunity, EarlyView.
This observational study assessed the association between anti‐type 2 biologic agents and the occurrence of autoimmune diseases using a large real‐world claims database. Anti‐IL‐5 and anti‐IgE therapies were associated with an increased occurrence of autoimmune diseases, including rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE ...
Shoichiro Inokuchi
wiley   +1 more source

Home - About - Disclaimer - Privacy